Email updates

Keep up to date with the latest news and content from BMC Medical Genomics and BioMed Central.

Open Access Research article

Decreased expression of GRAF1/OPHN-1-L in the X-linked alpha thalassemia mental retardation syndrome

Vincenza Barresi12, Angela Ragusa8, Marco Fichera7, Nicolò Musso1, Lucia Castiglia7, Giancarlo Rappazzo4, Salvatore Travali3, Teresa Mattina5, Corrado Romano7, Guido Cocchi6 and Daniele F Condorelli12*

Author Affiliations

1 Laboratorio sui Sistemi Complessi, Scuola Superiore di Catania, University of Catania, Catania, Italy

2 Section of Biochemistry and Molecular Biology, Department of Chemical Sciences, University of Catania, Catania, Italy

3 Department of Biomedical Sciences, University of Catania, Catania, Italy

4 Department of Animal Biology, University of Catania, Catania, Italy

5 Department of Pediatrics, University of Catania, Catania, Italy

6 ICPPN, Bologna, Italy

7 IRCCS OASI Maria SS Troina, Catania, Italy

8 UOC Diagnosi Prenatale Laboratorio di Genetica Umana AOU Policlinico-Vittorio Emanuele, Catania, Italy

For all author emails, please log on.

BMC Medical Genomics 2010, 3:28  doi:10.1186/1755-8794-3-28

Published: 6 July 2010

Abstract

Background

ATRX is a severe X-linked disorder characterized by mental retardation, facial dysmorphism, urogenital abnormalities and alpha-thalassemia. The disease is caused by mutations in ATRX gene, which encodes a protein belonging to the SWI/SNF DNA helicase family, a group of proteins involved in the regulation of gene transcription at the chromatin level. In order to identify specific genes involved in the pathogenesis of the disease, we compared, by cDNA microarray, the expression levels of approximately 8500 transcripts between ATRX and normal males of comparable age.

Methods

cDNA microarray was performed using total RNA from peripheral blood mononuclear cells of ATRX and normal males. Microarray results were validated by quantitative real-time polymerase chain reaction.

Results

cDNA microarray analysis showed that 35 genes had a lower expression (30-35% of controls) while 25 transcripts had a two-fold higher expression in comparison to controls. In the microarray results the probe for oligophrenin-1, a gene known for its involvement in mental retardation, showed a decreased hybridization signal. However, such gene was poorly expressed in blood mononuclear cells and its decrease was not confirmed in the quantitative real-time RT-PCR assay. On the other hand, the expression of an homologous gene, the GTPase regulator associated with the focal adhesion kinase 1/Oligophrenin-1-like (GRAF1/OPHN-1-L), was relatively high in blood mononuclear cells and significantly decreased in ATRX patients. The analysis of the expression pattern of the GRAF1/OPHN-1-L gene in human tissues and organs revealed the predominant brain expression of a novel splicing isoform, called variant-3.

Conclusions

Our data support the hypothesis of a primary role for altered gene expression in ATRX syndrome and suggest that the GRAF1/OPHN-1-L gene might be involved in the pathogenesis of the mental retardation. Moreover a novel alternative splicing transcript of such gene, predominantly expressed in brain tissues, was identified.